Acute Interstitial Nephritis
Acute interstitial nephritis is an immune-mediated kidney inflammation often triggered by common medications. Our nephrology team provides rapid diagnosis, steroid management, and dialysis support while kidneys recover.
Understanding Acute Interstitial Nephritis
Acute interstitial nephritis (AIN) is an inflammatory condition affecting the kidney's interstitium—the tissue surrounding the tubules. Unlike acute tubular necrosis, AIN is primarily immune-mediated and often triggered by medications.
Common culprit medications:
- NSAIDs: Ibuprofen, naproxen, and other anti-inflammatory drugs are among the most common causes
- Antibiotics: Beta-lactams (penicillins, cephalosporins), fluoroquinolones, sulfonamides, rifampin
- Proton pump inhibitors: Omeprazole, pantoprazole, and other PPIs—an increasingly recognized cause
- Other: Allopurinol, phenytoin, immune checkpoint inhibitors, and many more
Classic Triad (Often Incomplete)
Diagnosis often requires biopsy. The classic triad is present in only ~10% of cases. Kidney biopsy confirms the diagnosis and rules out other causes of AKI.
Our Approach to Acute Interstitial Nephritis
Rapid diagnosis, targeted treatment, and dialysis support while kidneys recover
Rapid Assessment
Prompt nephrology consultation to evaluate medication history, review urinalysis, and determine biopsy need. Time matters for kidney preservation.
Offending Agent Removal
Identification and immediate discontinuation of the causative medication. Alternative therapies coordinated with your care team.
Steroid Management
When indicated, corticosteroid therapy to suppress the immune response. Dosing and duration tailored to biopsy findings and clinical response.
Dialysis Bridge
If kidney function is severely impaired, dialysis support while steroids take effect. Most patients recover and discontinue dialysis.
Recovery Monitoring
Serial creatinine monitoring to track recovery. Steroid taper guided by response. Most patients improve within weeks.
Multidisciplinary Care
Collaboration with hospitalists, pharmacists, and specialists to manage underlying conditions while avoiding nephrotoxins.
For Hospitalists & Internists
AIN can be challenging to diagnose clinically, as the classic triad is often absent. We provide rapid nephrology consultation to help differentiate AIN from other causes of AKI and guide treatment decisions.
- Same-day nephrology consultation for suspected AIN
- Guidance on kidney biopsy indications and timing
- Steroid protocol recommendations based on evidence
- Dialysis support if severe AKI develops
- Medication review for potential nephrotoxins
- Follow-up to document recovery and prevent recurrence
Key Clinical Pearls
PPI-Induced AIN
Can occur months to years after PPI initiation. Consider in any unexplained AKI.
Checkpoint Inhibitor AIN
Immune-related AE in oncology patients. May require higher-dose steroids.
Biopsy Timing
If no improvement 3-5 days after stopping offending agent, biopsy guides steroid decision.
Frequently Asked Questions
Do steroids help in acute interstitial nephritis?
Evidence is mixed, but steroids are often used for biopsy-proven AIN, especially when there's no improvement after stopping the offending drug. Earlier steroid treatment (within 2 weeks) is associated with better outcomes than delayed treatment. We individualize decisions based on biopsy findings and clinical trajectory.
How long does it take for kidneys to recover from AIN?
With prompt drug discontinuation and, when indicated, steroid treatment, most patients show improvement within 1-3 weeks. Complete recovery may take several months. Some patients, particularly those with delayed diagnosis or severe disease, may have incomplete recovery.
Is kidney biopsy always necessary?
Not always, but it's often helpful. If there's a clear temporal relationship to a known culprit drug and improvement occurs after stopping it, biopsy may not be needed. However, biopsy is recommended when the diagnosis is uncertain, no improvement occurs after drug withdrawal, or steroids are being considered.
Can the patient ever take the offending medication again?
Generally no. There's a high risk of recurrence if re-exposed to the causative drug. We also recommend avoiding related medications in the same class when possible. Documentation in the medical record and patient education are essential.
What if the patient needs dialysis?
Dialysis may be necessary to support the patient while the kidney inflammation resolves. This is typically temporary, and most patients with AIN are able to discontinue dialysis as kidney function recovers with treatment.
Suspect Drug-Induced Kidney Injury?
If you have a patient with unexplained AKI and recent medication exposure, contact us for nephrology consultation. Early intervention improves outcomes.